TITLE

Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice

AUTHOR(S)
Dornonville de la Cour, C.; Lindqvist, A.; Egecioglu, E.; Tung, Y. C. L.; Surve, V.; Ohlsson, C.; Jansson, J.-O.; Erlanson-Albertsson, C.; Dickson, S. L.; Hákanson, R.
PUB. DATE
July 2005
SOURCE
Gut;Jul2005, Vol. 54 Issue 7, p907
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: The gastric hormone ghrelin has been reported to stimulate food intake, increase weight gain, and cause obesity but its precise physiological role remains unclear. We investigated the long term effects of gastrectomy evoked ghrelin deficiency and of daily ghrelin injections on daily food intake, body weight, fat mass, lean body mass, and bone mass in mice. Methods: Ghrelin was given by subcutaneous injections (12 nmol/mouse once daily) for eight weeks to young female mice subjected to gastrectomy or sham operation one week previously. Results: Gastrectomy reduced plasma concentrations of total ghrelin (octanoylated and des-octanoylated) and active (octanoylated) ghrelin by ∼80%. Immediately after injection of ghrelin, the plasma concentration was supraphysiological and was still elevated 16 hours later. Daily food intake was not affected by either gastrectomy or ghrelin treatment. The effect of ghrelin on meal initiation was not studied. At the end point of the study, mean body weight was 15% lower in gastrectomised mice than in sham operated mice (p<0.001); daily ghrelin injections for eight weeks partially prevented this weight loss. In sham operated mice, ghrelin had no effect on body weight. The weight of fat was reduced in gastrectomised mice (-30%; p<0.01). This effect was reversed by ghrelin, enhancing the weight of fat in sham operated mice also (+20%; p<0.05). Gastrectomy reduced lean body mass (-10%; p
ACCESSION #
17496254

 

Related Articles

  • Diet-induced obesity blunts the behavioural effects of ghrelin: studies in a mouse-progressive ratio task. Finger, Beate; Dinan, Timothy; Cryan, John // Psychopharmacology;Mar2012, Vol. 220 Issue 1, p173 

    Rational: The ghrelinergic system is implicated in the development of obesity and in modulating central reward systems. It has been reported that diet-induced obesity causes blunted responding on food intake to ghrelin administration, associated with central ghrelin resistance. Here we...

  • OBESITY: The mouse that eats less but gains weight. Alfred, Jane // Nature Reviews Genetics;Oct2000, Vol. 1 Issue 1, p7 

    Reports on a study which examined the phenotypic effects of inactivating the gene that encodes the mouse melanocrotin receptor 3 (Mc3r). Function of Mc3r in a feedback loop; Impact of Mc3r on food intake and the tendency to obesity of the mice models; Effect on adiposity.

  • Potato protease inhibitors inhibit food intake and increase circulating cholecystokinin levels by a trypsin-dependent mechanism. Komarnytsky, S.; Cook, A.; Raskin, I. // International Journal of Obesity;Feb2011, Vol. 35 Issue 2, p236 

    Objective:To investigate the mechanisms underlying the satiety-promoting effects of a novel protease inhibitor concentrate derived from potato (PPIC).Methods:The acute and prolonged effects of oral PPIC administration (100 mg kg−1 per day) on food intake, body weight and gastric emptying...

  • Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice. Cheverud, James M.; Vaughn, Ty T.; Pletscher, L. Susan; Peripato, Andrea C.; Adams, Emily S.; Erikson, Christopher F.; King-Ellison, Kelly J. // Mammalian Genome;Jan2001, Vol. 12 Issue 1, p3 

    The genetic basis of variation in obesity in human populations is thought to be owing to many genes of relatively small effect and their interactions. The LG/J by SM/J intercross of mouse inbred strains provides an excellent model system in which to investigate multigenic obesity. We previously...

  • Metabolic disease: Potassium channel blocker prevents obesity. Crunkhorn, Sarah // Nature Reviews Drug Discovery;Aug2013, Vol. 12 Issue 8, p577 

    The article presents a study that investigates the role of potassium channel blocker, Kv1.3, in treating obesity and other related disorders. Researchers performed a subcutaneous injection of ShK-186, KV1.3's peptide inhibitor, on mice on alternating days in a span of 45 days and they found that...

  • Coffee could prevent weight gain.  // Filipino Post;11/20/2014, p10 

    No abstract available.

  • Deficiency of Adiponectin Receptor 2 Increases Adiposity in Mice Fed a High Fat Diet. Yanfang Liu; Otto, Keith A.; Miller, Anne Reifel // Diabetes;Jun2007 Supplement 1, Vol. 56, pA350 

    Adiponectin/adiponectin receptors are involved in energy homeostasis and inflammatory pathways. We have previously shown that AdipoR2 deletion diminishes high fat diet (HF) induced dyslipidemia and insulin resistance, yet deteriorates glucose homeostasis as HF feeding continues, resulting from...

  • Brown and beige fat: development, function and therapeutic potential. Harms, Matthew; Seale, Patrick // Nature Medicine;Oct2013, Vol. 19 Issue 10, p1252 

    Adipose tissue, best known for its role in fat storage, can also suppress weight gain and metabolic disease through the action of specialized, heat-producing adipocytes. Brown adipocytes are located in dedicated depots and express constitutively high levels of thermogenic genes, whereas...

  • Appetite Enhancement and Weight Gain by Peripheral Administration of TrkB Agonists in Non-Human Primates. Lin, John C.; Tsao, David; Barras, Paul; Bastarrachea, Raul A.; Boyd, Bob; Chou, Joyce; Rosete, Rodnie; Hua Long; Forgie, Alison; Abdiche, Yasmina; Dilley, Jeanette; Stratton, Jennifer; Garcia, Carlos; Sloane, David L.; Comuzzie, Anthony G.; Rosenthal, Arnon // PLoS ONE;2008, Vol. 3 Issue 4, p1 

    Loss of function mutations in the receptor tyrosine kinase TrkB pathway resulted in hyperphagia and morbid obesity in human and rodents. Conversely, peripheral or central stimulation of TrkB by its natural ligands BDNF or NT4 reduced body weight and food intake in mice, supporting the idea that...